2017-2021 Germany HIV/AIDS Diagnostics Market: Emerging Opportunities and Growth Strategies

February 2017 | 250 pages | ID: G778974C876EN
Venture Planning Group

Abstracts

Complete report $2,300. DataPack (test volumes, sales forecasts, supplier shares) $1,500.

Summary

This report presents detailed analyses of the AIDS diagnostics market in Germany. The report provides test volume and sales forecasts for HIV-1/2/Combo, HIVAg/HIV NAT, Western Blot, HTLV-I/II and other confirmatory tests performed in the following market segments:

• Hospitals
• Commercial/Private Laboratories
• Blood Banks

In addition to test volume and sales projections, the report presents sales and market share estimates for major suppliers of AIDS tests.

Highlights

• Provides scientific views on the definition, epidemiology and etiology of AIDS and other retroviruses.
• Examines market applications of Molecular Diagnostics, Immunodiagnostics, IT and other emerging technologies.
• Reviews infectious disease testing analyzers marketed by Abbott, Beckman Coulter/Danaher, bioMerieux, Ortho-Clinical Diagnostics/J&J, Roche, Siemens, Tosoh and other suppliers.
• Profiles leading manufacturers and potential market entrants developing innovative technologies and products.
• Analyzes alternative market penetration strategies for suppliers.

Methodology

The report is based on a combination of primary and secondary information sources, including VPGMarketResearchs proprietary database developed during the course of over 100 syndicated studies and numerous proprietary single-client assignments. The database contains information on companies, technologies, products and executives worldwide. Moreover, a comprehensive review of the product and financial literature, business and technical periodicals, and pertinent industry analyst reports was conducted. Contains 250 pages and 7 tables

Contents

I. INTRODUCTION

II. A1DS/H4 WORLDWIDE MARKET AND TECHNOLOGY OVERVIEW

A. Background
B. Diagnostic Tests: H4-1/2/Combo, H4Ag/H4 NAT, Western Blot, HTL5-1/2
C. 5accines and Drugs
D. 1nstrumentation Review and Market Needs
E. Emerging Diagnostic Technologies

III. GERMANY: MARKET SIZE, GROWTH AND MAJOR SUPPLIERS' Sales and Market Shares

IV. ALTERNATIVE MARKET PENETRATION STRATEGIES

A. 1nternal Development
B. Collaborative Arrangements
C. University Contracts
D. Distribution Strategies for Decentralized Testing Markets
  1. MARKET1NG APPROACHES
  2. PRODUCT COMPLE11TY
  3. CUSTOMER PREFERENCE
  4. ESTABL1SHED SUPPL1ERS
  5. EMERG1NG SUPPL1ERS
  6. MAJOR TYPES OF D1STR1BUTORS
  7. MARKET SEGMENTAT1ON

V. POTENTIAL MARKET ENTRY BARRIERS AND RISKS

A. Market Maturity
B. Cost Containment
C. Competition
D. Technological Edge and Limitations
E. Patent Protection
F. Regulatory Constraints
G. Decentralized Testing Market Challenges

VI. COMPETITIVE ASSESSMENTS

Abbott
Affymetrix
Beckman Coulter/Danaher
Becton Dickinson
bioMerieux
Bio-Rad
Cepheid
Diamedix/Erba
DiaSorin
Eiken Chemical
Elitech Group
Enzo Biochem
Fujirebio
Grifols
Hologic/Gen-Probe
1D Biomedical/GSK
Kreatch/Leica
Lonza
Ortho-Clinical Diagnostics
Qiagen
Roche
Scienion
Sequenom
SeraCare
Siemens
Takara Bio
Thermo Fisher
Wallac/PE
Wako

L1ST OF TABLES

Table 1. Major Companies Developing or Marketing A1DS Tests
Table 2. Germany: H4 or H4-1/2/Combo Test 5olume and Sales Forecast by Market Segment
Table 3. Germany: H4 Ag Test 5olume and Sales Forecast by Market Segment
Table 4. Germany: Western Blot/Other Confirmatory Tests 5olume and Sales Forecast by Market Segment
Table 5. Germany: H4 NAT Blood Screening Test 5olume and Diagnostics Sales
Table 6. Germany: A1DS Diagnostics Market by Major Supplier
Table 7. Germany: H4 Blood Screening NAT Sales and Market Shares
of Major Suppliers